ADH1A

Alcohol dehydrogenase 1A · P07327 · ADH1A on Sugi Atlas →

25,434 patent compounds predicted against ADH1A, 11,939 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL39255 SCHEMBL39255 0.94 14/20
SCHEMBL59918 SCHEMBL59918 0.41 13/20
SCHEMBL329469 SCHEMBL329469 0.41 13/20
SCHEMBL493755 SCHEMBL493755 0.41 13/20
SCHEMBL536191 SCHEMBL536191 0.59 12/20
SCHEMBL528874 SCHEMBL528874 0.54 12/20
SCHEMBL411186 SCHEMBL411186 0.46 10/20
SCHEMBL15013 SCHEMBL15013 0.50 8/20
SCHEMBL283931 SCHEMBL283931 0.50 8/20
SCHEMBL612785 SCHEMBL612785 0.50 8/20
SCHEMBL612962 SCHEMBL612962 0.50 8/20
SCHEMBL296264 SCHEMBL296264 0.52 7/20
SCHEMBL303776 SCHEMBL303776 1.00 6/20
SCHEMBL23038 SCHEMBL23038 0.50 6/20
SCHEMBL304405 SCHEMBL304405 0.50 6/20
SCHEMBL460664 SCHEMBL460664 0.50 6/20
SCHEMBL245391 SCHEMBL245391 1.00 5/20
SCHEMBL645299 SCHEMBL645299 1.00 5/20
SCHEMBL302803 SCHEMBL302803 0.61 5/20
SCHEMBL150343 SCHEMBL150343 0.50 5/20

Clinical trials — most relevant to ADH1A by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Late Effects of Ethanol Intake on the Glucose Response to Subcutaneous Glucagon in Type 1 Diabetes PHASE4COMPLETED
Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential Tremor PHASE2COMPLETED
Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder PHASE2COMPLETED
A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease PHASE2COMPLETED
Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI) PHASE2COMPLETED
Non-oxidative Metabolite Profiles After Increasing Doses of Ethanol PHASE1COMPLETED
Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver Disease PHASE1NOT_YET_RECRUITING
The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects PHASE1RECRUITING
Nicotinic Receptor Genetic Variation and Alcohol Reward PHASE1RECRUITING
Study to Compare the Effects of Viagra® Vs Hezkue® in Healthy Fasted Male Participants. PHASE1NOT_YET_RECRUITING
ALDH2 Genetic Testing in East Asian Community nanNOT_YET_RECRUITING
Environmental and Biological Monitoring Pilot Study for Polycyclic Aromatic Hydrocarbons in Linxian, China nanCOMPLETED
Alcohol Metabolism and Disease Risk in Asians nanCOMPLETED
Bipolar Disorder With Alcoholism in Han Chinese nanUNKNOWN
Hepatic Lipid Metabolism-Alcohol Use Disorder nanRECRUITING
ALDH2 Single Nucleotide Polymorphisms and Prognosis of Esophageal Cancer Patients nanRECRUITING
Dose-response Effect of Alcohol Ingestion on Steroid Profile nanCOMPLETED
Clinical-Genetic Variation in GABA/Alcohol Sensitivity nanCOMPLETED
Alterations of Gut Microbiota and Metabolites in ALD Patients nanUNKNOWN
Endophenotyping With Functional Magnetic Resonance Imaging (fMRI) nanCOMPLETED
Adrenoleukodystrophy National Registry Study nanRECRUITING
Biobehavioral Pathways Underlying Alcohol Use and Health nanCOMPLETED
Alcoholic Liver Disease and the Gut Microbiome nanACTIVE_NOT_RECRUITING
Validation in Humans of Genes Involved in Alcohol Drinking, Stress-Induced Alcohol Drinking and Relapse nanCOMPLETED
Characterization Imaging Instruments in Alcoholics and Non-Alcoholics nanRECRUITING
Pharmacogenetics of Alcohol: Treatment Implications nanCOMPLETED
Moderate Alcohol Consumption, Risk of Cardiovascular Disease and Type 2 Diabetes: Influence of Alcohol Oxidation nanCOMPLETED
Complex Exploratory Study of Alcohol-Associated Hepatitis nanUNKNOWN
Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis nanCOMPLETED
Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a ADH1A binder may also engage these)

ProteinNameSimilarity
ADH1C Alcohol dehydrogenase 1C 1.000 landscape →
Q5RBP7 1.000 Q5RBP7 →
O97959 1.000 O97959 →
P00328 1.000 P00328 →
P86885 1.000 P86885 →
P28469 1.000 P28469 →
P80338 1.000 P80338 →
P00329 1.000 P00329 →
P14139 1.000 P14139 →
Q5R1W2 1.000 Q5R1W2 →
Q64415 1.000 Q64415 →
P19631 1.000 P19631 →
P00327 1.000 P00327 →
ADH1B All-trans-retinol dehydrogenase [NAD(+)] ADH1B 1.000 landscape →
P23991 1.000 P23991 →
P86883 1.000 P86883 →
P80222 1.000 P80222 →
Q03505 1.000 Q03505 →
P80512 1.000 P80512 →
P49645 1.000 P49645 →
P22797 1.000 P22797 →
O19053 1.000 O19053 →
P93629 0.999 P93629 →
P41680 0.999 P41680 →
P81601 0.999 P81601 →
P19854 0.999 P19854 →
P28474 0.999 P28474 →
Q3ZC42 0.998 Q3ZC42 →
Q64437 0.998 Q64437 →
Q9Z2M2 0.997 Q9Z2M2 →